| Literature DB >> 35568320 |
M Penado1, E R Serrano-Ibáñez2, T Corrás Vázquez2, M Del-Prado Morales2, M López-Flores2.
Abstract
BACKGROUND: The health crisis caused by the COVID-19 pandemic has led to a considerable increase in the psychopathology of COVID-19 patients and among the general population. This study aims to conduct the psychometric analysis of the scale of concern about COVID-19 in the Spanish population and to estimate the level of concern and dysfunctional anxiety present one year after the lockdown measures in Spain aimed at resisting the spread of the viral disease among the population.Entities:
Keywords: Anxiety; COVID-19; Concern; Contagion; Generalized anxiety disorder (GAD)
Mesh:
Year: 2022 PMID: 35568320 PMCID: PMC9093078 DOI: 10.1016/j.jad.2022.05.018
Source DB: PubMed Journal: J Affect Disord ISSN: 0165-0327 Impact factor: 6.533
Fig. 1Confirmatory factor analysis of the instrument.
Descriptive results of the COVID-19 concern scale, subjected to if they have or have not been infected with COVID-19.
| General | COVID patient | Not COVID patient | |||||
|---|---|---|---|---|---|---|---|
| EPCov-191 | 2.01 | 0.870 | 1.80 | 0.876 | 2.04 | 0.043 | |
| EPCov-192 | 1.74 | 0.830 | 1.61 | 0.769 | 1.74 | 0.820 | |
| EPCov-193 | 1.63 | 0.830 | 1.56 | 0.833 | 1.63 | 0.820 | |
| EPCov-194 | 2.50 | 0.752 | 2.49 | 0.780 | 2.51 | 0.753 | |
| EPCov-195 | 2.14 | 0.838 | 2.19 | 0.753 | 2.13 | 0.818 | |
| EPCov-196 | 2.14 | 0.942 | 2.08 | 0.822 | 2.14 | 0.962 | |
| EPCov-19Mean | 2.02 | 0.670 | 1.95 | 0.675 | 2.03 | 0.669 | |
Note. Mean (M). Standard Deviation (SD).
Descriptive results of the COVID-19 concern scale, subjected to gender.
| General | Male | Female | |||||
|---|---|---|---|---|---|---|---|
| EPCov-191 | 2.01 | 0.870 | 1.94 | 0.869 | 2.01 | 0.870 | |
| EPCov-192 | 1.74 | 0.830 | 1.61 | 0.792 | 1.79 | 0.840 | |
| EPCov-193 | 1.63 | 0.830 | 1.60 | 0.764 | 1.64 | 0.854 | |
| EPCov-194 | 2.50 | 0.752 | 2.36 | 0.715 | 2.54 | 0.754 | |
| EPCov-195 | 2.14 | 0.838 | 1.95 | 0.786 | 2.20 | 0.846 | |
| EPCov-196 | 2.14 | 0.942 | 2.04 | 0.927 | 2.18 | 0.947 | |
| EPCov-19Mean | 2.02 | 0.67 | 1.91 | 0.054 | 2.07 | 0.035 | |
Note. Mean (M); Standard Deviation (SD).
Descriptive results of the Penn State Worry Questionnaire (PSWQ), subjected to if they have or have not been infected with COVID-19.
| General | COVD patient | Not COVID patient | |||||
|---|---|---|---|---|---|---|---|
| PSWQ1 | 3.36 | 1.16 | 3.44 | 1.15 | 3.04 | 1.17 | |
| PSWQ2 | 3.25 | 1.17 | 3.28 | 1.17 | 3.10 | 1.19 | |
| PSWQ3 | 3.43 | 1.07 | 3.49 | 1.07 | 3.18 | 1.07 | |
| PSWQ4 | 3.15 | 1.12 | 3.19 | 1.10 | 2.98 | 1.20 | |
| PSWQ5 | 3.18 | 1.22 | 3.19 | 1.18 | 3.13 | 1.36 | |
| PSWQ6 | 3.30 | 1.16 | 3.33 | 1.12 | 3.18 | 1.30 | |
| PSWQ7 | 2.75 | 1.24 | 2.77 | 1.22 | 2.66 | 1.33 | |
| PSWQ8 | 3.02 | 1.21 | 3.03 | 1.19 | 2.98 | 1.31 | |
| PSWQ9 | 2.90 | 1.25 | 2.95 | 1.26 | 2.73 | 1.23 | |
| PSWQ10 | 2.39 | 1.30 | 2.39 | 1.31 | 2.39 | 1.27 | |
| PSWQ11 | 2.55 | 1.22 | 2.54 | 1.21 | 2.61 | 1.25 | |
| PSWQ12 | 2.18 | 1.18 | 2.20 | 1.19 | 2.11 | 1.17 | |
| PSWQ13 | 2.61 | 1.29 | 2.60 | 1.30 | 2.62 | 1.27 | |
| PSWQ14 | 2.59 | 1.24 | 2.60 | 1.23 | 2.55 | 1.27 | |
| PSWQ15 | 2.28 | 1.25 | 2.32 | 1.27 | 2.14 | 1.13 | |
| PSWQ16 | 3.32 | 1.16 | 3.36 | 1.18 | 3.14 | 1.09 | |
| PSWQMEAN | 2.89 | 0.96 | 2.87 | 0.99 | 2.92 | 0.95 | |
Note: *p < .05; **p < .01.
Descriptive results of Penn State Worry Questionnaire (PSWQ), subjected to gender.
| Male | Female | ||||
|---|---|---|---|---|---|
| PSWQ1** | 3.11 | 1.17 | 3.45 | 1.14 | |
| PSWQ2** | 2.83 | 1.09 | 3.39 | 1.17 | |
| PSWQ3** | 3.19 | 1.03 | 3.51 | 1.08 | |
| PSWQ4* | 2.95 | 1.07 | 3.22 | 1.14 | |
| PSWQ5** | 2.78 | 1.14 | 3.32 | 1.21 | |
| PSWQ6** | 2.98 | 1.14 | 3.42 | 1.14 | |
| PSWQ7* | 2.55 | 1.17 | 2.82 | 1.26 | |
| PSWQ8* | 2.80 | 1.17 | 3.10 | 1.22 | |
| PSWQ9* | 2.67 | 1.57 | 2.99 | 1.27 | |
| PSWQ10** | 2.08 | 1.10 | 2.51 | 1.36 | |
| PSWQ11** | 2.27 | 1.12 | 2.65 | 1.24 | |
| PSWQ12** | 1.95 | 0.96 | 2.26 | 1.24 | |
| PSWQ13 | 2.44 | 1.17 | 2.66 | 1.32 | |
| PSWQ14* | 2.40 | 1.14 | 2.65 | 1.27 | |
| PSWQ15* | 2.09 | 1.10 | 2.35 | 1.29 | |
| PSWQ16 | 3.22 | 1.04 | 3.35 | 1.21 | |
| PSWQMEAN | 2.65 | 0.84 | 2.98 | 0.99 | |
Percentage of the sample with scores indicative of anxiety disorders and generalized anxiety disorder.
| Total | Male | Female | COVID patient | Not COVID patient | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| No anxiety disorders | 194 | 38.6 | 61 | 46.9 | 132 | 35.7 | 42 | 42.4 | 152 | 37.7 |
| Nonspecific anxiety disorders | 200 | 39.8 | 54 | 41.5 | 145 | 39.2 | 40 | 40.4 | 160 | 39.7 |
| Generalized anxiety disorder | 108 | 21.5 | 15 | 11.5 | 93 | 25.1 | 17 | 17.2 | 91 | 22.6 |